Kenya Receives Ksh 59.7 Billion Health Grant for Treatment of Malaria, HIV, and Tuberculosis Kenya has received a substantial grant of Ksh 59.7 billion from the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) to support the country’s efforts in combating these deadly diseases. The grant will be utilized over a period of three years to provide treatment and prevention services for: * Malaria: The grant will fund the purchase of life-saving medicines, distribution of mosquito nets, and strengthening malaria surveillance systems. * HIV/AIDS: The grant will support the provision of antiviral medication, prevention campaigns, and community-based care and support programs. * Tuberculosis (TB): The funding will facilitate the procurement of antibiotics, rapid diagnostic tests, and support for patients with multi-drug resistant TB. This grant is a significant boost to Kenya’s healthcare system, which has been facing challenges in addressing the high burden of these diseases. Malaria remains a major cause of illness and death in Kenya, particularly in rural areas. HIV/AIDS affects an estimated 1.5 million Kenyans, while TB is the third leading cause of death in the country. “This grant is a lifeline for Kenyans who are battling these diseases,” said Dr. Patrick Amoth, Director-General of Health. “It will enable us to scale up our interventions, improve treatment outcomes, and save lives.” The grant will be implemented in partnership with the Ministry of Health, non-governmental organizations, and community-based organizations. The focus will be on strengthening health systems, improving access to quality healthcare services, and promoting behavior change to reduce the spread of these diseases. “The Global Fund has been a steadfast partner in Kenya’s fight against HIV/AIDS, malaria, and tuberculosis,” said Ambassador Simon Mochama, Chairman of the Global Fund Board. “This grant is a testament to the Fund’s commitment to supporting countries in achieving their health goals.” The grant is expected to have a significant impact on the health and well-being of Kenyans. It will contribute to reducing the burden of these diseases, improving the quality of life for those affected, and strengthening the country’s healthcare system.Kenya Receives Grant to Combat HIV/AIDS, Tuberculosis, and MalariaKenya Receives Grant to Combat HIV/AIDS, Tuberculosis, and Malaria Kenya has received a grant of Ksh59.7 billion (USD 407,989,068) from the Global Fund to strengthen its efforts in combating HIV/AIDS, tuberculosis, and malaria. The grant, which will be implemented over a three-year period (July 2024 to June 2027), is expected to reinforce community and health systems to enhance access to quality healthcare services. The Global Fund, a partnership of governments, civil society organizations, and individuals affected by these diseases, aims to accelerate the end of the HIV/AIDS, tuberculosis, and malaria epidemics worldwide. Key Areas of Focus The grant will be used to support various initiatives, including: * Providing quality care and prevention services for individuals with tuberculosis, leprosy, and lung diseases * Strengthening social support and expanding the Social Health Insurance Fund (SHIF) coverage for vulnerable patients * Achieving Universal Health Coverage through comprehensive prevention, treatment, and care * Reducing malaria incidence and deaths by at least 75% by 2027 * Procuring essential commodities, such as medicines, laboratory supplies, and testing kits Investment in KEMSA The Global Fund has also invested 1.2 billion Kenya shillings (US$9.5 million) in the construction, equipping, and digitalization of the KEMSA National Supply Chain Centre. This investment will enhance the supply chain, support service delivery in Primary Health Care, and strengthen responses to pandemics and emergencies. Recent Progress This grant comes at a time when Kenya has reported significant progress in combating HIV/AIDS. New HIV infections have declined by 78%, while mortality attributed to HIV has decreased by 68%. Mother-to-child transmission has also been reduced by 65%.Kenya has received a Ksh 59.7 billion health grant from the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM). The grant will be used to support the country’s efforts to prevent, diagnose and treat these diseases. The grant will be used to improve access to essential health services, including HIV testing and counseling, antiretroviral therapy, tuberculosis diagnosis and treatment, and malaria prevention and control. The grant will also be used to strengthen health systems, including the supply chain for essential medicines and commodities, and to support community-based health programs. The GFATM grant is a significant investment in Kenya’s health sector. It will help to save lives and improve the health of millions of Kenyans. The grant will also help to strengthen the country’s health system and make it more resilient to future health threats. Kenya is one of the largest recipients of GFATM funding in the world. The country has made significant progress in the fight against AIDS, Tuberculosis and Malaria in recent years, and the GFATM grant will help to sustain these gains. The GFATM is a global partnership that invests in the prevention, diagnosis and treatment of AIDS, Tuberculosis and Malaria. The Fund is a major supporter of health programs in low- and middle-income countries, and it has helped to save millions of lives.